The SEC made its recommendations in respect of the accelerated approval process request of the SII, Bharat Biotech International Ltd as well as about phase-III trials of Cadila Healthcare Ltd.
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
India's drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.
Telangana Minister for Industry and Information Technology K.T. Rama Rao on Sunday congratulated Bharat Biotech after its Covid-19 vaccine Covaxin received emergency use approval from the drug regulator.Rama Rao congratulated the .
India approves AstraZeneca, local COVID vaccines bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.